Ranking Profile - Arcturus Therapeutics Ltd

Introduction

Arcturus Therapeutics Holdings Inc (Arcturus) formerly Arcturus Therapeutics Ltd, is a pharmaceutical company that develops a portfolio of nucleic acid therapeutics for treatment of diseases. The company discovers and develops RNA medicines and design and utilize lipid-mediated drug delivery systems. Arcturu’s pipeline products portfolio include ARCT-810 (LUNAR-OTC), ARCT-032 (LUNAR-CF), ARCT-021 (LUNAR-COV19 Vaccine) and LUNAR Flu. It provides messenger RNA (mRNA), that is used as protein replacement therapy to treat diseases caused by a lack of protein and by defective proteins for cystic fibrosis. The company RNA therapeutics includes programs pursuing rare diseases, Hepatitis B, non-alcoholic steatohepatitis (NASH), cystic fibrosis, and COVID-19. Arcturus is headquartered in San Diego, California, the US.